These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 30373175

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In Vitro Cytotoxicity of Trastuzumab (Tz) and Se-Trastuzumab (Se-Tz) against the Her/2 Breast Cancer Cell Lines JIMT-1 and BT-474.
    Bapat P, Sewell DG, Boylan M, Sharma AK, Spallholz JE.
    Int J Mol Sci; 2021 Apr 28; 22(9):. PubMed ID: 33925081
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer.
    Abdollahpour-Alitappeh M, Lotfinia M, Bagheri N, Sineh Sepehr K, Habibi-Anbouhi M, Kobarfard F, Balalaie S, Foroumadi A, Abbaszadeh-Goudarzi G, Abbaszadeh-Goudarzi K, Abolhassani M.
    J Cell Physiol; 2019 Mar 28; 234(3):2693-2704. PubMed ID: 30246298
    [Abstract] [Full Text] [Related]

  • 7. A novel humanized MUC1 antibody-drug conjugate for the treatment of trastuzumab-resistant breast cancer.
    Wu G, Li L, Qiu Y, Sun W, Ren T, Lv Y, Liu M, Wang X, Tao H, Zhao L, Cao J, He L, Li H, Gu H.
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec 08; 53(12):1625-1639. PubMed ID: 34586349
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS, Ho Y, Lin YW, Naveen Raj E, Liu KK, Chen C, Zhou XZ, Lu KP, Chao JI.
    Acta Biomater; 2019 Mar 01; 86():395-405. PubMed ID: 30660004
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antibody drug conjugates for patients with breast cancer.
    Medford A, Spring LM, Moy B, Bardia A.
    Curr Probl Cancer; 2021 Oct 01; 45(5):100795. PubMed ID: 34635342
    [Abstract] [Full Text] [Related]

  • 14. Development and biological assessment of MMAE-trastuzumab antibody-drug conjugates (ADCs).
    Yaghoubi S, Gharibi T, Karimi MH, Sadeqi Nezhad M, Seifalian A, Tavakkol R, Bagheri N, Dezhkam A, Abdollahpour-Alitappeh M.
    Breast Cancer; 2021 Jan 01; 28(1):216-225. PubMed ID: 32889587
    [Abstract] [Full Text] [Related]

  • 15. Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand.
    Amoury M, Bauerschlag D, Zeppernick F, von Felbert V, Berges N, Di Fiore S, Mintert I, Bleilevens A, Maass N, Bräutigam K, Meinhold-Heerlein I, Stickeler E, Barth S, Fischer R, Hussain AF.
    Oncotarget; 2016 Aug 23; 7(34):54925-54936. PubMed ID: 27448975
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dose-dependent cell cycle arrest and apoptosis in HER2 breast cancer cells by177Lu-CHX-A"-DTPA-Trastuzumab.
    Sharma R, Kameswaran M, Pandey U, Dash A.
    J Cancer Res Ther; 2020 Aug 23; 16(6):1426-1434. PubMed ID: 33342808
    [Abstract] [Full Text] [Related]

  • 18. Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer.
    Liu D, Cardillo TM, Wang Y, Rossi EA, Goldenberg DM, Chang CH.
    Mol Cancer; 2014 Mar 10; 13():53. PubMed ID: 24606732
    [Abstract] [Full Text] [Related]

  • 19. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y, Hu S, Chen Y, Zhang X, Gao H, Tian J, Chen J.
    Phytomedicine; 2023 Sep 10; 118():154924. PubMed ID: 37393829
    [Abstract] [Full Text] [Related]

  • 20. Selenocystine-induced cell apoptosis and S-phase arrest inhibit human triple-negative breast cancer cell proliferation.
    Long M, Wu J, Hao J, Liu W, Tang Y, Li X, Su H, Qiu W.
    In Vitro Cell Dev Biol Anim; 2015 Nov 10; 51(10):1077-84. PubMed ID: 26194802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.